Literature DB >> 29157397

Progressive Forms of Multiple Sclerosis: Distinct Entity or Age-Dependent Phenomena.

Burcu Zeydan1, Orhun H Kantarci2.   

Abstract

In multiple sclerosis (MS), disease course is defined by a subclinical or clinical relapsing remitting phase, a progressive phase, and the overlapping phase in-between. Each phase can have intermittently active or inactive periods. Subclinical activity in radiologically isolated syndrome evolving to primary-progressive MS is mostly indistinguishable from relapsing-remitting MS evolving to secondary-progressive MS. The onset of progressive-phase MS is age-dependent but time and pre-progressive phase agnostic. Pathologic hallmarks of progressive MS onset also appear to be age-dependent but pre-progressive phase agnostic. Onset of progressive MS is characterized by a peak in smoldering plaques.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Multiple sclerosis; Progression; Smoldering plaque

Mesh:

Year:  2018        PMID: 29157397     DOI: 10.1016/j.ncl.2017.08.006

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  16 in total

Review 1.  Toxic Air Pollutants and Their Effect on Multiple Sclerosis: A Review Study.

Authors:  Mohammad Javad Mohammadi; Kourosh Zarea; Nasser Hatamzadeh; Arash Salahshouri; Asaad Sharhani
Journal:  Front Public Health       Date:  2022-07-06

2.  Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.

Authors:  Francisco Coret; Francisco C Pérez-Miralles; Francisco Gascón; Carmen Alcalá; Arantxa Navarré; Ana Bernad; Isabel Boscá; Matilde Escutia; Sara Gil-Perotin; Bonaventura Casanova
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-06-26

Review 3.  SeXX Matters in Multiple Sclerosis.

Authors:  Francesca Gilli; Krista D DiSano; Andrew R Pachner
Journal:  Front Neurol       Date:  2020-07-03       Impact factor: 4.003

4.  The Role of Optical Coherence Tomography in Differential Diagnosis of Multiple Sclerosis and Autoimmune Connective Tissue Diseases with CNS Involvement.

Authors:  Paula Wildner; Ewa Zydorczak; Magdalena Oset; Małgorzata Siger; Michał Wilczyński; Mariusz Stasiołek; Mariola Matysiak
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

Review 5.  Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions.

Authors:  Alessandra Musella; Antonietta Gentile; Francesca Romana Rizzo; Francesca De Vito; Diego Fresegna; Silvia Bullitta; Valentina Vanni; Livia Guadalupi; Mario Stampanoni Bassi; Fabio Buttari; Diego Centonze; Georgia Mandolesi
Journal:  Front Aging Neurosci       Date:  2018-08-08       Impact factor: 5.750

6.  Functional and self-care capacity of people with multiple sclerosis.

Authors:  Ana Railka de Souza Oliveira-Kumakura; Larissa Maria Bezutti; Juliany Lino Gomes Silva; Renata Cristina Gasparino
Journal:  Rev Lat Am Enfermagem       Date:  2019-10-07

7.  Integrated Cognitive and Neuromotor Rehabilitation in Multiple Sclerosis: A Pragmatic Study.

Authors:  Anna M Barbarulo; Giacomo Lus; Elisabetta Signoriello; Luigi Trojano; Dario Grossi; Mariateresa Esposito; Teresa Costabile; Roberta Lanzillo; Francesco Saccà; Vincenzo Brescia Morra; Giovannina Conchiglia
Journal:  Front Behav Neurosci       Date:  2018-09-05       Impact factor: 3.558

8.  Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?

Authors:  João J Cerqueira; D Alastair S Compston; Ruth Geraldes; Mario M Rosa; Klaus Schmierer; Alan Thompson; Michela Tinelli; Jacqueline Palace
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-04-04       Impact factor: 10.154

Review 9.  Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.

Authors:  Hans Lassmann
Journal:  Front Immunol       Date:  2019-01-10       Impact factor: 7.561

10.  Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune encephalomyelitis.

Authors:  Isabella Wimmer; Cornelia Scharler; Tobias Zrzavy; Taro Kadowaki; Verena Mödlagl; Kim Rojc; Anna R Tröscher; Maja Kitic; Shuichi Ueda; Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol Commun       Date:  2019-01-31       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.